Neoadjuvant chemotherapy in stage IB2 to IB3 cervical cancer: because we can or because we must?

Philippe Morice, Sebastien Gouy, Marie Plante, Nadeem Abu-Rustum

Résultats de recherche: Contribution à un journal › Editorial

langue originale	Anglais
Numéro d'article	101770
journal	International Journal of Gynecological Cancer
Volume	35
Numéro de publication	6
Les DOIs	https://doi.org/10.1016/j.ijgc.2025.101770
état	Publié - 1 juin 2025

Accès au document

@article{1d1cbdb4800f465da52af24333f60d37,

title = "Neoadjuvant chemotherapy in stage IB2 to IB3 cervical cancer: because we can or because we must?",

author = "Philippe Morice and Sebastien Gouy and Marie Plante and Nadeem Abu-Rustum",

year = "2025",

month = jun,

day = "1",

doi = "10.1016/j.ijgc.2025.101770",

language = "English",

volume = "35",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

number = "6",

}

TY - JOUR

T1 - Neoadjuvant chemotherapy in stage IB2 to IB3 cervical cancer

T2 - because we can or because we must?

AU - Morice, Philippe

AU - Gouy, Sebastien

AU - Plante, Marie

AU - Abu-Rustum, Nadeem

PY - 2025/6/1

Y1 - 2025/6/1

UR - http://www.scopus.com/inward/record.url?scp=105001704352&partnerID=8YFLogxK

U2 - 10.1016/j.ijgc.2025.101770

DO - 10.1016/j.ijgc.2025.101770

M3 - Editorial

AN - SCOPUS:105001704352

SN - 1048-891X

VL - 35

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

IS - 6

M1 - 101770

ER -